Active, Not Recruiting Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer NCT04673448 Conditions Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +53 more Locations Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States View Trial Details
